These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32860034)

  • 1. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Bouabdallaoui N; Tardif JC; Waters DD; Pinto FJ; Maggioni AP; Diaz R; Berry C; Koenig W; Lopez-Sendon J; Gamra H; Kiwan GS; Blondeau L; Orfanos A; Ibrahim R; Grégoire JC; Dubé MP; Samuel M; Morel O; Lim P; Bertrand OF; Kouz S; Guertin MC; L'Allier PL; Roubille F
    Eur Heart J; 2020 Nov; 41(42):4092-4099. PubMed ID: 32860034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    Tardif JC; Kouz S; Waters DD; Bertrand OF; Diaz R; Maggioni AP; Pinto FJ; Ibrahim R; Gamra H; Kiwan GS; Berry C; López-Sendón J; Ostadal P; Koenig W; Angoulvant D; Grégoire JC; Lavoie MA; Dubé MP; Rhainds D; Provencher M; Blondeau L; Orfanos A; L'Allier PL; Guertin MC; Roubille F
    N Engl J Med; 2019 Dec; 381(26):2497-2505. PubMed ID: 31733140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Samuel M; Tardif JC; Khairy P; Roubille F; Waters DD; Grégoire JC; Pinto FJ; Maggioni AP; Diaz R; Berry C; Koenig W; Ostadal P; Lopez-Sendon J; Gamra H; Kiwan GS; Dubé MP; Provencher M; Orfanos A; Blondeau L; Kouz S; L'Allier PL; Ibrahim R; Bouabdallaoui N; Mitchell D; Guertin MC; Lelorier J
    Eur Heart J Qual Care Clin Outcomes; 2021 Sep; 7(5):486-495. PubMed ID: 32407460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.
    Dubé MP; Legault MA; Lemaçon A; Lemieux Perreault LP; Fouodjio R; Waters DD; Kouz S; Pinto FJ; Maggioni AP; Diaz R; Berry C; Koenig W; Lopez-Sendon J; Gamra H; Kiwan GS; Asselin G; Provost S; Barhdadi A; Sun M; Cossette M; Blondeau L; Mongrain I; Dubois A; Rhainds D; Bouabdallaoui N; Samuel M; de Denus S; L'Allier PL; Guertin MC; Roubille F; Tardif JC
    Circ Genom Precis Med; 2021 Apr; 14(2):e003183. PubMed ID: 33560138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Roubille F; Bouabdallaoui N; Kouz S; Waters DD; Diaz R; Maggioni AP; Pinto FJ; Grégoire JC; Gamra H; Kiwan GS; Berry C; López-Sendón J; Koenig W; Delorme L; Elbaz M; Coste P; Provencher M; Bassevitch Z; Blondeau L; L'Allier PL; Guertin MC; Tardif JC
    Diabetes Care; 2024 Mar; 47(3):467-470. PubMed ID: 38181203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Sun M; Dubé MP; Hennessy T; Schultz CJ; Barhdadi A; Rhainds D; Hillis GS; Tardif JC
    Int J Cardiol; 2022 Sep; 363():20-22. PubMed ID: 35716932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.
    Lamas GA; Goertz C; Boineau R; Mark DB; Rozema T; Nahin RL; Lindblad L; Lewis EF; Drisko J; Lee KL;
    JAMA; 2013 Mar; 309(12):1241-50. PubMed ID: 23532240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G
    Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y
    Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
    Opstal TSJ; Fiolet ATL; van Broekhoven A; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Duyvendak M; van Eck JWM; van Beek EA; den Hartog F; Budgeon CA; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH;
    J Am Coll Cardiol; 2021 Aug; 78(9):859-866. PubMed ID: 34446156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine in Patients with Chronic Coronary Disease.
    Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu XF; Ireland MA; Lenderink T; Latchem D; Hoogslag P; Jerzewski A; Nierop P; Whelan A; Hendriks R; Swart H; Schaap J; Kuijper AFM; van Hessen MWJ; Saklani P; Tan I; Thompson AG; Morton A; Judkins C; Bax WA; Dirksen M; Alings M; Hankey GJ; Budgeon CA; Tijssen JGP; Cornel JH; Thompson PL;
    N Engl J Med; 2020 Nov; 383(19):1838-1847. PubMed ID: 32865380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis.
    Nogic J; Mehta O; Tong D; Brown AJ; Layland J
    Cardiol Ther; 2023 Mar; 12(1):171-181. PubMed ID: 36609745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
    Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
    Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
    J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
    Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
    Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
    Tegn N; Abdelnoor M; Aaberge L; Endresen K; Smith P; Aakhus S; Gjertsen E; Dahl-Hofseth O; Ranhoff AH; Gullestad L; Bendz B;
    Lancet; 2016 Mar; 387(10023):1057-1065. PubMed ID: 26794722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial.
    Pavasini R; Campo G; Serenelli M; Tonet E; Guiducci V; Escaned J; Moreno R; Casella G; Cavazza C; Varbella F; Sacchetta G; Arena M; Santos IA; Ibañes EG; Scarsini R; D'Amico G; Ruiz-Poveda FL; Díez Gil JL; Pignatelli G; Iannopollo G; Colaiori I; Santos RC; Marrone A; Fileti L; Rigattieri S; Barbato E; Ocaranza-Sanchez R; Biscaglia S
    Eur J Prev Cardiol; 2024 Sep; 31(12):1451-1459. PubMed ID: 38452238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial.
    Gencer B; Mach F; Murphy SA; De Ferrari GM; Huber K; Lewis BS; Ferreira J; Kurtz CE; Wang H; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS; Giugliano RP
    JAMA Cardiol; 2020 Aug; 5(8):952-957. PubMed ID: 32432684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
    Mewton N; Roubille F; Bresson D; Prieur C; Bouleti C; Bochaton T; Ivanes F; Dubreuil O; Biere L; Hayek A; Derimay F; Akodad M; Alos B; Haider L; El Jonhy N; Daw R; De Bourguignon C; Dhelens C; Finet G; Bonnefoy-Cudraz E; Bidaux G; Boutitie F; Maucort-Boulch D; Croisille P; Rioufol G; Prunier F; Angoulvant D
    Circulation; 2021 Sep; 144(11):859-869. PubMed ID: 34420373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.